Drug Delivery Systems for Ocular Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 72
Special Issue Editors
Interests: dry eye; myopia; contact lenses; ocular biochemistry; glaucoma
Special Issues, Collections and Topics in MDPI journals
Interests: biomaterials characterization; hydrogels; polymeric micelles; drug delivery systems; controlled release; ocular delivery; drug-loaded contact lenses; antibiofilm medical devices
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to our Special Issue on drug delivery systems for ocular diseases. It is known that topical instillation for the treatment of ocular diseases has important deficiencies, mainly due to the permeability barrier of the ocular surface. To improve the drug efficacy with low concentrations, new drug release systems have been developed in recent years. These systems allow for an increase in the release time and in drug penetration, enhancing the drug efficacy and tolerance.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: drug delivery systems, contact lens delivery, nanoparticles, liposomes, microneedles, and nanocarriers.
We look forward to receiving your contributions.
Prof. Dr. Gonzalo Carracedo
Dr. Maria Vivero-Lopez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular diseases
- contact lens delivery
- drug delivery systems
- nanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
